WallStreetZenWallStreetZen

NASDAQ: ABCL
Abcellera Biologics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Abcellera Biologics revenue was $28.83M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $5.1M, down 22.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ABCL annual revenue was $28.8M, with -24.2% growth year-over-year.

ABCL past revenue growth

How has ABCL's revenue growth performed historically?

Company
-24.17%
Industry
497.69%
Market
20.68%
ABCL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABCL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ABCL's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ABCL revenue history

Current Revenue
$28.8M
Current Earnings
-$162.9M
Current Profit Margin
-564.8%

Be the first to know when ABCL announces revenue.

ABCL Revenue History By Year

ABCL Yearly RevenueABCL RevenueABCL ChangeABCL Revenue Growth
2024-12-31$28.83M-$9.19M-24.17%
2023-12-31$38.03M-$447.40M-92.17%
2022-12-31$485.42M$110.22M+29.38%
2021-12-31$375.20M$142.05M+60.92%
2020-12-31$233.16M$221.54M+1,907.88%
2019-12-31$11.61M$2.78M+31.49%
2018-12-31$8.83MN/AN/A

1 of 1

Abcellera Biologics Revenue FAQ

What was ABCL's revenue last quarter?

On Invalid Date, Abcellera Biologics (NASDAQ: ABCL) reported Q4 2024 revenue of $5.05 million up 44.98% year over year. In the same quarter last year, Abcellera Biologics's revenue was $9.18 million.

What was Abcellera Biologics's revenue in 2024?

Abcellera Biologics's annual revenue for the twelve months ending Dec 31, 2024 was $28.83 million, a 24.17% decrease year over year.

How much does Abcellera Biologics make in a day?

Based on Abcellera Biologics annual revenue for the past five years, ABCL makes an average of $635,967.12 per day.

What was Abcellera Biologics's annual revenue growth in the past year?

As of Q2 2025, Abcellera Biologics's revenue has grown -24.17% year over year. This is 521.87 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Abcellera Biologics's revenue in the past year totaled $28.83 million.

How much does Abcellera Biologics make in a year?

Abcellera Biologics's revenue by year for the past five years is:
  • Abcellera Biologics's revenue for the twelve months ending Dec 31, 2024 was $28.83 million, a 24.17% decrease year over year.
  • Abcellera Biologics's annual revenue for Dec 31, 2023 was $38.03 million, a 92.17% decrease from 2022.
  • Abcellera Biologics's annual revenue for 2022 was $485.42 million, a 29.38% increase from 2021.
  • Abcellera Biologics's annual revenue for 2021 was $375.20 million, a 60.92% increase from 2020.
  • Abcellera Biologics's annual revenue for 2020 was $233.16 million, a 1,907.88% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.